Home > Press > Patent Office Grants NaturalNano Key Patent for Use of Halloysite NanoTubes in Polymeric Nanoparticle Composite as Strengthening and Performance Enhancing Component
Abstract:
In this patent, the Patent Office recognized the use of HNT additives as a key component of materials used to enhance mechanical properties in materials for electrical shielding and may also may be used enhance the performance of eluting agents.
NaturalNano, Inc. (OTCBB: NNAN) announced that the US Patent & Trademark Office has issued to the Company a patent covering the use of NNAN's proprietary Halloysite NanoTubes (HNT) in polymeric composite materials including Nano-particle Fillers as a key strengthening component to enhance the performance.
NaturalNano's CEO James Wemett commented, "With the issuance of this US Patent NNAN continues to expand and protect the commercial applications for our HNT additives. In this patent, the Patent Office recognized the use of HNT additives as a key component of materials used to enhance mechanical properties in materials for electrical shielding and may also may be used enhance the performance of eluting agents . Our patent portfolio continues to grow, strengthening our position as the world leader in the industrial applications for Halloysite materials. These unique materials are available under either exclusive or non-exclusive licenses."
####
About NaturalNano, Inc.
NaturalNano, Inc. (OTCBB: NNAN) is a materials science company focused on developing and commercializing advanced nanocomposites. The Company is focused on additive technologies and processes, including its proprietary Pleximer that adds value to industrial polymers, plastics and composites. NaturalNano holds and/or licenses20 patents and applications relating to Halloysite, as well as proprietary know-how for its extraction and separation processes, compositions, and derivatives. www.naturalnano.com
Cautionary Statement Regarding Forward-Looking Statements:
Contains forward-looking statements regarding future events and future performance that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-K and quarterly reports on Form 10-Q filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by
law.
For more information, please click here
Contacts:
Jim Wemett
NaturalNano, Inc.
585-267-4848
Tom Morabito
Park Avenue Investor Relations
585-586-7786
Copyright © NaturalNano, Inc.
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Materials/Metamaterials/Magnetoresistance
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||